Global Anemia Treatment Market size is expected to be worth around USD 19.1 Billion by 2033, from USD 9.7 Billion in 2023, growing at a CAGR of 7.2% Lawrence John Prudour +91 91308 55334 ...

Preoperatively assessing anemia as a modifiable risk factor may counteract increased mortality risk for patients with severe ...

Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.It ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

The deal comes at a time when the Anglo-Swedish pharma company is facing a string of investigations in the country, ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...

Simmie White is taking control of her own story. The six-year-old girl and her mother want others to understand more about ...

Why should you care? The answer is empathy. When we empathize with others, we make decisions that are greater than ourselves.

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

Researchers from the Mitochondrial Medicine Program at Children's Hospital of Philadelphia (CHOP) have better characterized a spectrum of what were classically considered discrete mitochondrial DNA ...

Strategic Financial Concepts LLC acquired a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) during the ...